Arixtra (fondaparinux sodium), the first in a new class of SYNTHETIC antithrombotics
Organon is now launching Arixtra (fondaparinux sodium), the first in a new class of SYNTHETIC antithrombotics.
It's even smaller than the low-molecular weight heparins.
This smaller size allows it to bind more selectively to factor Xa to inhibit thrombin formation.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote